Mark D. Horsey
Director of Finance/CFO at StemBioSys, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Steven A. Davis | M | - |
StemBioSys, Inc.
 StemBioSys, Inc. BiotechnologyHealth Technology StemBioSys, Inc. develops stem cell technologies. The firm develops technology on the isolation and expansion of specialized adult stem cells for clinical use. Its technology is called XC-marrowECM, which is a patented extracellular matrix laid down by human bone marrow mesenchymal stem cells. The company was founded by Xiao-Dong Chen and Steven A. Davis in 2010 and is headquartered in San Antonio, TX. | 14 years |
| John W. Feik | M | - |
StemBioSys, Inc.
StemBioSys, Inc. BiotechnologyHealth Technology StemBioSys, Inc. develops stem cell technologies. The firm develops technology on the isolation and expansion of specialized adult stem cells for clinical use. Its technology is called XC-marrowECM, which is a patented extracellular matrix laid down by human bone marrow mesenchymal stem cells. The company was founded by Xiao-Dong Chen and Steven A. Davis in 2010 and is headquartered in San Antonio, TX.
Emtora Biosciences, Inc.
 Emtora Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Emtora Biosciences, Inc. operates as a drug development company which focuses on disease treatment and prevention through agents that modulate the mTor pathway in mammals. It produces drugs to slow the aging process and its efficacy in treating age-related diseases. The company was founded in 2012 and is headquartered in San Antonio, TX. | 10 years |
| Xiao-Dong Chen | M | - |
StemBioSys, Inc.
StemBioSys, Inc. BiotechnologyHealth Technology StemBioSys, Inc. develops stem cell technologies. The firm develops technology on the isolation and expansion of specialized adult stem cells for clinical use. Its technology is called XC-marrowECM, which is a patented extracellular matrix laid down by human bone marrow mesenchymal stem cells. The company was founded by Xiao-Dong Chen and Steven A. Davis in 2010 and is headquartered in San Antonio, TX. | 14 years |
| H. Randall Goldsmith | M | - |
Emtora Biosciences, Inc.
Emtora Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Emtora Biosciences, Inc. operates as a drug development company which focuses on disease treatment and prevention through agents that modulate the mTor pathway in mammals. It produces drugs to slow the aging process and its efficacy in treating age-related diseases. The company was founded in 2012 and is headquartered in San Antonio, TX. | - |
| Robert Hutchens | M | - |
StemBioSys, Inc.
StemBioSys, Inc. BiotechnologyHealth Technology StemBioSys, Inc. develops stem cell technologies. The firm develops technology on the isolation and expansion of specialized adult stem cells for clinical use. Its technology is called XC-marrowECM, which is a patented extracellular matrix laid down by human bone marrow mesenchymal stem cells. The company was founded by Xiao-Dong Chen and Steven A. Davis in 2010 and is headquartered in San Antonio, TX. | - |
| Robert Langer | M | 74 |
StemBioSys, Inc.
StemBioSys, Inc. BiotechnologyHealth Technology StemBioSys, Inc. develops stem cell technologies. The firm develops technology on the isolation and expansion of specialized adult stem cells for clinical use. Its technology is called XC-marrowECM, which is a patented extracellular matrix laid down by human bone marrow mesenchymal stem cells. The company was founded by Xiao-Dong Chen and Steven A. Davis in 2010 and is headquartered in San Antonio, TX. | - |
| Fred Dinger | M | - |
StemBioSys, Inc.
StemBioSys, Inc. BiotechnologyHealth Technology StemBioSys, Inc. develops stem cell technologies. The firm develops technology on the isolation and expansion of specialized adult stem cells for clinical use. Its technology is called XC-marrowECM, which is a patented extracellular matrix laid down by human bone marrow mesenchymal stem cells. The company was founded by Xiao-Dong Chen and Steven A. Davis in 2010 and is headquartered in San Antonio, TX. | - |
| Bruce B. Barshop | M | - |
Emtora Biosciences, Inc.
Emtora Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Emtora Biosciences, Inc. operates as a drug development company which focuses on disease treatment and prevention through agents that modulate the mTor pathway in mammals. It produces drugs to slow the aging process and its efficacy in treating age-related diseases. The company was founded in 2012 and is headquartered in San Antonio, TX. | - |
| Paul Castella | M | - |
StemBioSys, Inc.
StemBioSys, Inc. BiotechnologyHealth Technology StemBioSys, Inc. develops stem cell technologies. The firm develops technology on the isolation and expansion of specialized adult stem cells for clinical use. Its technology is called XC-marrowECM, which is a patented extracellular matrix laid down by human bone marrow mesenchymal stem cells. The company was founded by Xiao-Dong Chen and Steven A. Davis in 2010 and is headquartered in San Antonio, TX. | - |
| Stephen M. Dufilho | M | - |
Emtora Biosciences, Inc.
Emtora Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Emtora Biosciences, Inc. operates as a drug development company which focuses on disease treatment and prevention through agents that modulate the mTor pathway in mammals. It produces drugs to slow the aging process and its efficacy in treating age-related diseases. The company was founded in 2012 and is headquartered in San Antonio, TX. | - |
| Ian William David Clements | M | - |
StemBioSys, Inc.
StemBioSys, Inc. BiotechnologyHealth Technology StemBioSys, Inc. develops stem cell technologies. The firm develops technology on the isolation and expansion of specialized adult stem cells for clinical use. Its technology is called XC-marrowECM, which is a patented extracellular matrix laid down by human bone marrow mesenchymal stem cells. The company was founded by Xiao-Dong Chen and Steven A. Davis in 2010 and is headquartered in San Antonio, TX. | - |
| Jean Cheever | F | - |
StemBioSys, Inc.
StemBioSys, Inc. BiotechnologyHealth Technology StemBioSys, Inc. develops stem cell technologies. The firm develops technology on the isolation and expansion of specialized adult stem cells for clinical use. Its technology is called XC-marrowECM, which is a patented extracellular matrix laid down by human bone marrow mesenchymal stem cells. The company was founded by Xiao-Dong Chen and Steven A. Davis in 2010 and is headquartered in San Antonio, TX. | - |
| Randi Brosterman Hutchens | F | - |
Emtora Biosciences, Inc.
Emtora Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Emtora Biosciences, Inc. operates as a drug development company which focuses on disease treatment and prevention through agents that modulate the mTor pathway in mammals. It produces drugs to slow the aging process and its efficacy in treating age-related diseases. The company was founded in 2012 and is headquartered in San Antonio, TX. | - |
| Becky Butler Cap | F | - |
StemBioSys, Inc.
StemBioSys, Inc. BiotechnologyHealth Technology StemBioSys, Inc. develops stem cell technologies. The firm develops technology on the isolation and expansion of specialized adult stem cells for clinical use. Its technology is called XC-marrowECM, which is a patented extracellular matrix laid down by human bone marrow mesenchymal stem cells. The company was founded by Xiao-Dong Chen and Steven A. Davis in 2010 and is headquartered in San Antonio, TX. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peter Savas | M | 75 |
StemBioSys, Inc.
StemBioSys, Inc. BiotechnologyHealth Technology StemBioSys, Inc. develops stem cell technologies. The firm develops technology on the isolation and expansion of specialized adult stem cells for clinical use. Its technology is called XC-marrowECM, which is a patented extracellular matrix laid down by human bone marrow mesenchymal stem cells. The company was founded by Xiao-Dong Chen and Steven A. Davis in 2010 and is headquartered in San Antonio, TX. | 1 years |
| Catherine Burzik | F | 73 |
StemBioSys, Inc.
StemBioSys, Inc. BiotechnologyHealth Technology StemBioSys, Inc. develops stem cell technologies. The firm develops technology on the isolation and expansion of specialized adult stem cells for clinical use. Its technology is called XC-marrowECM, which is a patented extracellular matrix laid down by human bone marrow mesenchymal stem cells. The company was founded by Xiao-Dong Chen and Steven A. Davis in 2010 and is headquartered in San Antonio, TX. | - |
| Sy Griffey | M | - |
StemBioSys, Inc.
StemBioSys, Inc. BiotechnologyHealth Technology StemBioSys, Inc. develops stem cell technologies. The firm develops technology on the isolation and expansion of specialized adult stem cells for clinical use. Its technology is called XC-marrowECM, which is a patented extracellular matrix laid down by human bone marrow mesenchymal stem cells. The company was founded by Xiao-Dong Chen and Steven A. Davis in 2010 and is headquartered in San Antonio, TX. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 17 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Mark D. Horsey
- Personal Network
